Mio Mejima

2.2k total citations
27 papers, 1.6k citations indexed

About

Mio Mejima is a scholar working on Biotechnology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mio Mejima has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biotechnology, 14 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Mio Mejima's work include Transgenic Plants and Applications (16 papers), CRISPR and Genetic Engineering (7 papers) and Viral gastroenteritis research and epidemiology (6 papers). Mio Mejima is often cited by papers focused on Transgenic Plants and Applications (16 papers), CRISPR and Genetic Engineering (7 papers) and Viral gastroenteritis research and epidemiology (6 papers). Mio Mejima collaborates with scholars based in Japan, United States and Egypt. Mio Mejima's co-authors include Yoshikazu Yuki, Tomonori Nochi, Shiho Kurokawa, Hiroshi Kiyono, Daisuke Tokuhara, Kazunari Akiyoshi, Shunji Kozaki, Tomoko Kohda, Hiroshi Kiyono and Haruko Takahashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Mio Mejima

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mio Mejima Japan	18	716	490	461	348	182	27	1.6k
Shiho Kurokawa Japan	18	614 0.9×	390 0.8×	288 0.6×	290 0.8×	187 1.0×	35	1.4k
Jonathan A. Meulbroek United States	14	683 1.0×	507 1.0×	87 0.2×	351 1.0×	177 1.0×	17	2.0k
M. Ann Clark United Kingdom	22	823 1.1×	782 1.6×	138 0.3×	407 1.2×	113 0.6×	30	2.2k
Jacquelyn Kilbourne United States	21	438 0.6×	175 0.4×	362 0.8×	252 0.7×	118 0.6×	43	1.3k
Peter M. Moyle Australia	28	1.1k 1.5×	705 1.4×	59 0.1×	360 1.0×	161 0.9×	66	2.1k
Nani Wibowo Australia	11	492 0.7×	451 0.9×	73 0.2×	351 1.0×	82 0.5×	20	1.3k
Dinesh Chandra India	19	417 0.6×	486 1.0×	316 0.7×	251 0.7×	127 0.7×	61	1.8k
Margaret A. Baird New Zealand	25	786 1.1×	766 1.6×	154 0.3×	277 0.8×	42 0.2×	71	1.8k
Young Bong Kim South Korea	25	755 1.1×	336 0.7×	69 0.1×	293 0.8×	261 1.4×	111	1.9k
Xiuru Li China	19	725 1.0×	243 0.5×	76 0.2×	202 0.6×	81 0.4×	54	1.5k

Countries citing papers authored by Mio Mejima

Since Specialization

Citations

This map shows the geographic impact of Mio Mejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mio Mejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mio Mejima more than expected).

Fields of papers citing papers by Mio Mejima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mio Mejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mio Mejima. The network helps show where Mio Mejima may publish in the future.

Co-authorship network of co-authors of Mio Mejima

This figure shows the co-authorship network connecting the top 25 collaborators of Mio Mejima. A scholar is included among the top collaborators of Mio Mejima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mio Mejima. Mio Mejima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuki, Yoshikazu, Shiho Kurokawa, Koji Kashima, et al.. (2024). MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system. Frontiers in Plant Science. 15. 1342662–1342662. 7 indexed citations

Yuki, Yoshikazu, Masanori Nojima, Osamu Hosono, et al.. (2021). Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial. The Lancet Microbe. 2(9). e429–e440. 34 indexed citations

Azegami, Tatsuhiko, Yoshikazu Yuki, Shin‐ichi Sawada, et al.. (2017). Nanogel-based nasal ghrelin vaccine prevents obesity. Mucosal Immunology. 10(5). 1351–1360. 36 indexed citations

Ogawa, Takumi, Koji Kashima, Yoshikazu Yuki, et al.. (2017). Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit. Scientific Reports. 7(1). 5196–5196. 11 indexed citations

Yuki, Yoshikazu, Shiho Kurokawa, Hiroko Kozuka‐Hata, et al.. (2016). Differential analyses of major allergen proteins in wild-type rice and rice producing a fragment of anti-rotavirus antibody. Regulatory Toxicology and Pharmacology. 76. 128–136. 4 indexed citations

Kashima, Koji, Yoshikazu Yuki, Mio Mejima, et al.. (2015). Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants. Plant Cell Reports. 35(3). 667–679. 23 indexed citations

Kashima, Koji, Mio Mejima, Shiho Kurokawa, et al.. (2015). Comparative whole-genome analyses of selection marker–free rice-based cholera toxin B-subunit vaccine lines and wild-type lines. BMC Genomics. 16(1). 48–48. 12 indexed citations

Takeyama, Natsumi, Yoshikazu Yuki, Daisuke Tokuhara, et al.. (2015). Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs. Vaccine. 33(39). 5204–5211. 20 indexed citations

Fukuyama, Yoshiko, Yoshikazu Yuki, Yuko Katakai, et al.. (2015). Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunology. 8(5). 1144–1153. 79 indexed citations

10.

Yuki, Yoshikazu, Shiho Kurokawa, Mio Mejima, et al.. (2014). A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice. Journal of Biotechnology. 175. 45–52. 15 indexed citations

11.

Tokuhara, Daisuke, Tomonori Nochi, Akiko Matsumura, et al.. (2014). Specific Expression of Apolipoprotein A-IV in the Follicle-Associated Epithelium of the Small Intestine. Digestive Diseases and Sciences. 59(11). 2682–2692. 6 indexed citations

12.

Tokuhara, Daisuke, Beatriz Álvarez, Mio Mejima, et al.. (2013). Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. Journal of Clinical Investigation. 123(9). 3829–3838. 67 indexed citations

13.

Kurokawa, Shiho, Masaharu Kuroda, Mio Mejima, et al.. (2013). RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds. Plant Cell Reports. 33(1). 75–87. 21 indexed citations

14.

Kurokawa, Shiho, Rika Nakamura, Mio Mejima, et al.. (2013). MucoRice-cholera Toxin B-subunit, a Rice-based Oral Cholera Vaccine, Down-regulates the Expression of α-Amylase/trypsin Inhibitor-like Protein Family as Major Rice Allergens. Journal of Proteome Research. 12(7). 3372–3382. 23 indexed citations

15.

Yuki, Yoshikazu, Il Gyu Kong, Ayuko Sato, et al.. (2012). Adjuvant-free nanogel-based PspA nasal vaccine for the induction of protective immunity against Pneumococcus (166.7). The Journal of Immunology. 188(1_Supplement). 166.7–166.7. 6 indexed citations

16.

Yuki, Yoshikazu, Mio Mejima, Shiho Kurokawa, et al.. (2012). RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine. Vaccine. 30(28). 4160–4166. 25 indexed citations

17.

Nochi, Tomonori, Yoshikazu Yuki, Haruko Takahashi, et al.. (2010). Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nature Materials. 9(7). 572–578. 369 indexed citations

18.

Yuki, Yoshikazu, Daisuke Tokuhara, Tomonori Nochi, et al.. (2009). Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine. 27(43). 5982–5988. 30 indexed citations

19.

Nochi, Tomonori, Yoshikazu Yuki, Akiko Matsumura, et al.. (2007). A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. The Journal of Experimental Medicine. 204(12). 2789–2796. 139 indexed citations

20.

Nochi, Tomonori, Hidenori Takagi, Yoshikazu Yuki, et al.. (2007). Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proceedings of the National Academy of Sciences. 104(26). 10986–10991. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact